Go to
JCI Insight
Citations to this article
Z Wang, … , M A Ghatei, S R Bloom
Published January 1, 1995
Citation Information: J Clin Invest. 1995;95(1):417-421. https://doi.org/10.1172/JCI117671.
Citation Information: J Clin Invest. 1995;95(1):417-421. https://doi.org/10.1172/JCI117671.
Abstract
Authors
Z Wang, R M Wang, A A Owji, D M Smith, M A Ghatei, S R Bloom
Total citations by year
Citation information
Citations to this article (145)
| Title and authors | Publication | Year |
|---|---|---|
|
Effect of gastric distension with concurrent small intestinal saline or glucose infusion on incretin hormone secretion in healthy individuals: A randomized, controlled, crossover study
Jalleh RJ, Trahair LG, Wu T, Standfield S, Feinle\u2010Bisset C, Rayner CK, Horowitz M, Jones KL |
Diabetes, obesity & metabolism | 2023 |
|
The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
MA Nauck, DR Quast, J Wefers, AF Pfeiffer |
Diabetes, obesity & metabolism | 2021 |
|
Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats
VN Marty, M Farokhnia, JJ Munier, Y Mulpuri, L Leggio, I Spigelman |
Frontiers in neuroscience | 2020 |
|
The core clock gene, Bmal1, and its downstream target, the SNARE regulatory protein secretagogin, are necessary for circadian secretion of glucagon-like peptide-1
AD Biancolin, A Martchenko, E Mitova, P Gurges, E Michalchyshyn, JA Chalmers, A Doria, JC Mychaleckyj, AE Adriaenssens, F Reimann, FM Gribble, M Gil-Lozano, BJ Cox, PL Brubaker |
Molecular Metabolism | 2020 |
|
The Effect of Morinda citrifolia L. Fruit Juice on the Blood Sugar Level and Other Serum Parameters in Patients with Diabetes Type 2
P Algenstaedt, A Stumpenhagen, J Westendorf |
Evidence-Based Complementary and Alternative Medicine | 2018 |
|
Implication of neurohormonal-coupled mechanisms of gastric emptying and pancreatic secretory function in diabetic gastroparesis
BM Mussa, S Sood, AJ Verberne |
World journal of gastroenterology : WJG | 2018 |
|
The SNARE Protein Syntaxin-1a Plays an Essential Role in Biphasic Exocytosis of the Incretin Hormone Glucagon-Like Peptide 1
SE Wheeler, HM Stacey, Y Nahaei, SJ Hale, AB Hardy, F Reimann, FM Gribble, P Larraufie, HY Gaisano, PL Brubaker |
Diabetes | 2017 |
|
Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry
M Yang, J Wang, S Wu, L Yuan, X Zhao, C Liu, J Xie, Y Jia, Y Lai, AZ Zhao, G Boden, L Li, G Yang |
Cell Death and Disease | 2017 |
|
Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis
CC Schmitt, T Aranias, T Viel, D Chateau, ML Gall, AJ Waligora-Dupriet, C Melchior, O Rouxel, N Kapel, G Gourcerol, B Tavitian, A Lehuen, E Brot-Laroche, A Leturque, P Serradas, A Grosfeld |
Molecular Metabolism | 2017 |
|
The physiological role of the brain GLP-1 system in stress
MK Holt, S Trapp, W Wisden |
Cogent Biology | 2016 |
|
Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
AM Bodnaruc, D Prudhomme, R Blanchet, I Giroux |
Nutrition & Metabolism | 2016 |
|
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee |
Endocrinology: Adult and Pediatric | 2016 |
|
Endocrinology
C Napier, SH Pearce |
Endocrinology | 2016 |
|
Targets and probes for non-invasive imaging of β-cells
A Jodal, R Schibli, M Béhé |
European Journal of Nuclear Medicine and Molecular Imaging | 2016 |
|
Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice: GLP-1 and microvascular thrombosis in endotoxaemia
S Steven, K Jurk, M Kopp, S Kröller-Schön, Y Mikhed, K Schwierczek, S Roohani, F Kashani, M Oelze, T Klein, S Tokalov, S Danckwardt, S Strand, P Wenzel, T Münzel, A Daiber |
British Journal of Pharmacology | 2016 |
|
Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
FA Duca, PV Bauer, SC Hamr, TK Lam |
Cell Metabolism | 2015 |
|
Changes in gut hormones and leptin in military personnel during operational deployment in Afghanistan: Gut Hormones in Deployed Military Personnel
NE Hill, JL Fallowfield, SK Delves, C Ardley, M Stacey, M Ghatei, SR Bloom, G Frost, SJ Brett, DR Wilson, KG Murphy |
Obesity | 2015 |
|
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
JS Kulve, DJ Veltman, L Bloemendaal, F Barkhof, CF Deacon, JJ Holst, RJ Konrad, JH Sloan, ML Drent, M Diamant, RG IJzerman |
Diabetologia | 2015 |
|
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
|
Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients: Metabolic syndrome and GLP-1 in T1DM
K Blaslov, T Bulum, K Zibar, L Duvnjak |
Journal of Diabetes | 2014 |
|
Nutrient-specific feeding and endocrine effects of jejunal infusions in obese animals
MJ Dailey, AA Moghadam, TH Moran |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2014 |
|
Peripheral Mechanisms in Appetite Regulation
M Camilleri |
Gastroenterology | 2014 |
|
Indirect effects of glucagon-like peptide-1 receptor agonist exendin-4 on the peripheral circadian clocks in mice
H Ando, K Ushijima, A Fujimura |
PloS one | 2013 |
|
Indirect Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Peripheral Circadian Clocks in Mice
H Ando, K Ushijima, A Fujimura, N Cermakian |
PloS one | 2013 |
|
Targeting the glucagon receptor family for diabetes and obesity therapy
YM Cho, CE Merchant, TJ Kieffer |
Pharmacology & Therapeutics | 2012 |
|
Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms
ML Vetter, S Ritter, TA Wadden, DB Sarwer |
Diabetes spectrum : a publication of the American Diabetes Association | 2012 |
|
Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats
MB Mumphrey, LM Patterson, H Zheng, HR Berthoud |
Neurogastroenterology and Motility | 2012 |
|
Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus
M Dharmalingam, U Sriram, MP Baruah |
Indian journal of endocrinology and metabolism | 2011 |
|
Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
M Punjabi, M Arnold, N Geary, W Langhans, G Pacheco-López |
Physiology & Behavior | 2011 |
|
Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities
E Mossello, E Ballini, M Boncinelli, M Monami, G Lonetto, AM Mello, F Tarantini, S Baldasseroni, E Mannucci, N Marchionni |
Experimental Diabetes Research | 2011 |
|
GIP: No Longer the Neglected Incretin Twin?
RN Kulkarni |
Science Translational Medicine | 2010 |
|
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
M Yamaoka-Tojo, T Tojo, N Takahira, A Matsunaga, N Aoyama, T Masuda, T Izumi |
Cardiovascular Diabetology | 2010 |
|
GLP-1 playing the role of a gut regulatory compound
PM Hellström |
Acta Physiologica | 2010 |
|
Glucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells
D Prabakaran, B Wang, JD Feuerstein, JA Sinclair, P Bijpuria, LI Jepeal, MM Wolfe |
Regulatory Peptides | 2010 |
|
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
BL Furman |
Toxicon | 2010 |
|
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
|
Incretin-based therapies for type 2 diabetes: a nurse’s perspective
J Hodgkiss |
British Journal of Nursing | 2010 |
|
A Novel Human-Based Receptor Antagonist of Sustained Action Reveals Body Weight Control by Endogenous GLP-1
JT Patterson, N Ottaway, VM Gelfanov, DL Smiley, D Perez-Tilve, PT Pfluger, MH Tschöp, RD DiMarchi |
ACS chemical biology | 2010 |
|
Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies
K Ban, S Hui, DJ Drucker, M Husain |
Journal of the American Society of Hypertension | 2009 |
|
Duodenal-Jejunal Exclusion Improves Glucose Tolerance in the Diabetic, Goto-Kakizaki Rat by a GLP-1 Receptor-Mediated Mechanism
TL Kindel, SM Yoder, RJ Seeley, DA D’Alessio, P Tso |
Journal of Gastrointestinal Surgery | 2009 |
|
Diabetes in Women
A Tsatsoulis, J Wyckoff, FM Brown |
2009 | |
|
Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism.
Kindel TL, Yoder SM, Seeley RJ, D'Alessio DA, Tso P |
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract | 2009 |
|
CNS GLP-1 regulation of peripheral glucose homeostasis
D Sandoval |
Physiology & Behavior | 2008 |
|
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
W Kim, JM Egan |
Pharmacological reviews | 2008 |
|
Handbook of Prebiotics
F Guarner |
Handbook of Prebiotics | 2008 |
|
Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulates Transepithelial Glucose Transport
SK Singh, AC Bartoo, S Krishnan, MO Boylan, JH Schwartz, MM Wolfe |
Obesity | 2008 |
|
Exendin-(9–39) Corrects Fasting Hypoglycemia in SUR-1–/– Mice by Lowering cAMP in Pancreatic β-Cells and Inhibiting Insulin Secretion*
DD de León, C Li, MI Delson, FM Matschinsky, CA Stanley, DA Stoffers |
The Journal of biological chemistry | 2008 |
|
Exendin-(9–39) Corrects Fasting Hypoglycemia in SUR-1–/– Mice by Lowering cAMP in Pancreatic β-Cells and Inhibiting Insulin Secretion
DD de León, C Li, MI Delson, FM Matschinsky, CA Stanley, DA Stoffers |
The Journal of biological chemistry | 2008 |
|
Integrated Response to a Meal
SJ Pandol |
JPEN. Journal of parenteral and enteral nutrition | 2008 |
|
Integrated response to a meal.
Pandol SJ |
JPEN. Journal of parenteral and enteral nutrition | 2008 |
|
Intestinal Regulation of Glucose
Daniel J. Drucker |
Journal of Clinical Investigation | 2007 |
|
GLP-1 receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
Torsten P. Vahl, Miyuki Tauchi, Timothy S. Durler, Eileen E. Elfers, Timothy M. Fernandes, Ronald D. Bitner, Kay S. Ellis, Stephen C. Woods, Randy J. Seeley, James P. Herman, David A. D’Alessio |
Endocrinology | 2007 |
|
Glucose-Dependent Insulinotropic Polypeptide Enhances Adipocyte Development and Glucose Uptake in Part Through Akt Activation
DH Song, L Getty-Kaushik, E Tseng, J Simon, BE Corkey, MM Wolfe |
Gastroenterology | 2007 |
|
Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system
D D'Alessio, W Lu, W Sun, S Zheng, Q Yang, R Seeley, SC Woods, P Tso |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2007 |
|
Pharmacotherapy of Diabetes: New Developments
CE Mogensen |
2007 | |
|
Central control of glucose homeostasis
A Puglianiello, S Cianfarani |
The review of diabetic studies : RDS | 2006 |
|
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank |
2006 | |
|
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank |
2006 | |
|
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank |
2006 | |
|
Integrated Upper Gastrointestinal Response to Food Intake
M Camilleri |
Gastroenterology | 2006 |
|
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, HJ Woerle, B Göke |
Gut | 2006 |
|
Physiology of the Gastrointestinal Tract
DJ Drucker |
Physiology of the Gastrointestinal Tract | 2006 |
|
Sp1/Sp3 binding is associated with cell-specific expression of the glucose-dependent insulinotropic polypeptide receptor gene
MO Boylan, LI Jepeal, MM Wolfe |
American journal of physiology. Endocrinology and metabolism | 2006 |
|
New ways in which GLP-1 can regulate glucose homeostasis
DA D'Alessio, DA Sandoval, RJ Seeley |
Journal of Clinical Investigation | 2005 |
|
The incretins: a link between nutrients and well-being
R Burcelin |
British Journal of Nutrition | 2005 |
|
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier, MA Nauck |
Diabetes/Metabolism Research and Reviews | 2005 |
|
Beta-cell expression of a dominant-negative HNF-1α compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice
B Ahrén, MS Winzell, B Burkey, TE Hughes |
European Journal of Pharmacology | 2005 |
|
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
T Hansotia, DJ Drucker |
Regulatory Peptides | 2005 |
|
The physiological role of GLP-1 in human: incretin, ileal brake or more?
J Schirra, B Göke |
Regulatory Peptides | 2005 |
|
Pharmacotherapy of Obesity
FX Pi–Sunyer |
Pharmacotherapy of Obesity | 2004 |
|
Gut peptides in the treatment of diabetes mellitus
TP Vahl, DA D’Alessio |
Expert Opinion on Investigational Drugs | 2004 |
|
Glucagon-like peptide-1 and glucagon-like peptide-2
LL Baggio, DJ Drucker |
Best Practice & Research Clinical Endocrinology & Metabolism | 2004 |
|
Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors
JJ Holst |
Expert Opinion on Emerging Drugs | 2004 |
|
Incretins, insulin secretion and Type 2 diabetes mellitus
T Vilsbøll, JJ Holst |
Diabetologia | 2004 |
|
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes
DA D'Alessio, TP Vahl |
American journal of physiology. Endocrinology and metabolism | 2004 |
|
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
JJ Holst, J Gromada |
American journal of physiology. Endocrinology and metabolism | 2004 |
|
Ingestion of Guar Gum Hydrolysate, a Soluble and Fermentable Nondigestible Saccharide, Improves Glucose Intolerance and Prevents Hypertriglyceridemia in Rats Fed Fructose
T Suzuki, H Hara |
The Journal of nutrition | 2004 |
|
Minireview: Gut Peptides Regulating Satiety
MR Druce, CJ Small, SR Bloom |
Endocrinology | 2004 |
|
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini |
International Textbook of Diabetes Mellitus | 2003 |
|
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
DJ Drucker |
Expert Opinion on Investigational Drugs | 2003 |
|
Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells
A Suzuki, H Nakauchi, H Taniguchi |
Proceedings of the National Academy of Sciences | 2003 |
|
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects
T Vilsbøll, T Krarup, S Madsbad, JJ Holst |
Regulatory Peptides | 2003 |
|
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin
VA Gault, FP O'Harte, P Harriott, MH Mooney, BD Green, PR Flatt |
Diabetologia | 2003 |
|
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
US Jhala, G Canettieri, RA Screaton, RN Kulkarni, S Krajewski, J Reed, J Walker, X Lin, M White, M Montminy |
Genes & development | 2003 |
|
Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
JJ Holst |
Diabetes/Metabolism Research and Reviews | 2002 |
|
Characterization of the Cellular and Metabolic Effects of a Novel Enzyme-Resistant Antagonist of Glucose-Dependent Insulinotropic Polypeptide
VA Gault, FP O'Harte, P Harriott, PR Flatt |
Biochemical and Biophysical Research Communications | 2002 |
|
Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons
M Kakei, T Yada, A Nakagawa, H Nakabayashi |
Autonomic Neuroscience | 2002 |
|
Gastric Inhibitory Polypeptide Analogues: Do They Have a Therapeutic Role in Diabetes Mellitus Similar to That of Glucagon-Like Peptide-1?
JJ Holst |
BioDrugs | 2002 |
|
Ectopeptidases
J Langner, S Ansorge |
2002 | |
|
Effects of pituitary adenylate cyclase activating polypeptide on lumbosacral preganglionic neurons in the neonatal rat spinal cord
A Miura, M Kawatani, WC de Groat |
Brain Research | 2001 |
|
Incretin hormones - an update
JJ Ørskov |
Scandinavian Journal of Clinical & Laboratory Investigation | 2001 |
|
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
CM Edwards, SA Stanley, R Davis, AE Brynes, GS Frost, LJ Seal, MA Ghatei, SR Bloom |
American journal of physiology. Endocrinology and metabolism | 2001 |
|
Minireview: The Glucagon-Like Peptides
DJ Drucker |
Endocrinology | 2001 |
|
Oxyntomodulin Inhibits Food Intake in the Rat
CL Dakin, I Gunn, CJ Small, CM Edwards, DL Hay, DM Smith, MA Ghatei, SR Bloom |
Endocrinology | 2001 |
|
Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat - evidence for a novel binding site subtype in cardiac and skeletal muscle
F Satoh, DM Smith, JV Gardiner, M Mahmoodi, KG Murphy, MA Ghatei, SR Bloom |
British Journal of Pharmacology | 2000 |
|
Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
R Perfetti, J Zhou, ME Doyle, JM Egan |
Endocrinology | 2000 |
|
The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor
M Nishizawa, H Nakabayashi, K Kawai, T Ito, S Kawakami, A Nakagawa, A Niijima, K Uchida |
Journal of the Autonomic Nervous System | 2000 |
|
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish
S Mojsov |
American Zoologist | 2000 |
|
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish1
S Mojsov |
American Zoologist | 2000 |
|
Characterization of Human and Rat Glucagon-Like Peptide-1 Receptors in the Neurointermediate Lobe: Lack of Coupling to Either Stimulation or Inhibition of Adenylyl Cyclase*
F Satoh, SA Beak, CJ Small, M Falzon, MA Ghatei, SR Bloom, DM Smith |
Endocrinology | 2000 |
|
Editorial: Targeted Gene Disruption in Endocrine Research—The Case of Glucagon-Like Peptide-1 and Neuroendocrine Function
RJ Seeley, SC Woods, D DAlessio |
Endocrinology | 2000 |
|
Control of Glucose Homeostasis by Incretin Hormones
R Perfetti, TA Brown, R Velikina, S Busselen |
Diabetes Technology & Therapeutics | 1999 |
|
Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1
JJ Holst |
Expert Opinion on Investigational Drugs | 1999 |
|
Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
JJ Holst |
Trends in Endocrinology & Metabolism | 1999 |
|
Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats
HJ Kissler, H Gepp, A Schmiedl, PO Schwille |
Metabolism | 1999 |
|
Properties of native and in vitro glycosylated forms of the glucagon-like peptide-1 receptor antagonist exendin (9–39)
JA Meurer, JR Colca, PS Burton, ÅP Elhammer |
Metabolism | 1999 |
|
Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7–36) Amide or Exendin-(9–39) Alters Body Weight in the Rat 1
K Meeran, D OShea, CM Edwards, MD Turton, MM Heath, I Gunn, S Abusnana, M Rossi, CJ Small, AP Goldstone, GM Taylor, D Sunter, J Steere, SJ Choi, MA Ghatei, SR Bloom |
Endocrinology | 1999 |
|
GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans
E Näslund, J Bogefors, S Skogar, P Grybäck, H Jacobsson, JJ Holst, PM Hellström |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 1999 |
|
Whole body glucose metabolism
K Zierler |
American journal of physiology. Endocrinology and metabolism | 1999 |
|
Effect of GIP and GLP-1 antagonists on insulin release in the rat
CC Tseng, XY Zhang, MM Wolfe |
American journal of physiology. Endocrinology and metabolism | 1999 |
|
Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
RP Boushey, B Yusta, DJ Drucker |
American journal of physiology. Endocrinology and metabolism | 1999 |
|
INSULIN AND INTRACELLULAR CALCIUM RESPONSIVENESS TO GLUCAGON-LIKE PEPTIDE-1 AND PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE BY DISPERSED ADULT PORCINE ISLET CELLS1:
AM Davalli, F Bertuzzi, C Meoni, L Scaglia, C Socci, G Pozza, AE Pontiroli |
Transplantation | 1999 |
|
The Glucagon-Like Peptides
TJ Kieffer, JF Habener |
Endocrine reviews | 1999 |
|
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans
J Schirra, K Sturm, P Leicht, R Arnold, B Göke, M Katschinski |
Journal of Clinical Investigation | 1998 |
|
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans
A Flint, A Raben, A Astrup, JJ Holst |
Journal of Clinical Investigation | 1998 |
|
Is There Appetite after GLP-1 and PACAP?
J Christophe |
Annals of the New York Academy of Sciences | 1998 |
|
Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans
A Wettergren, L Pridal, M Wøjdemann, JJ Holst |
Regulatory Peptides | 1998 |
|
Effect of Chronic Central Administration of Glucagon-Like Peptide-1 (7-36) Amide on Food Consumption and Body Weight in Normal and Obese Rats
HR Davis, DE Mullins, JM Pines, LM Hoos, CF France, DS Compton, MP Graziano, EJ Sybertz, CD Strader, M Heek |
Obesity research | 1998 |
|
[Ca 2+ ] i -reducing action of cAMP in rat pancreatic β-cells: involvement of thapsigargin-sensitive stores
K Yaekura, T Yada |
American journal of physiology. Cell physiology | 1998 |
|
Effects of Aging and a High Fat Diet on Body Weight and Glucose Tolerance in Glucagon-Like Peptide-1 Receptor−/− Mice*
LA Scrocchi, DJ Drucker |
Endocrinology | 1998 |
|
Exendin-(9–39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3′,5′-Monophosphate Levels and β-Cell Glucose Competence**This work was supported by Grant 31-46958.96 from the Swiss National Science Foundation (to B.T.)
V Serre, W Dolci, E Schaerer, L Scrocchi, D Drucker, S Efrat, B Thorens |
Endocrinology | 1998 |
|
Strategies and Potential Molecular Targets for Obesity Treatment
LA Campfield, FJ Smith, P Burn |
Science | 1998 |
|
Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats
Y Wang, R Perfetti, NH Greig, HW Holloway, KA DeOre, C Montrose-Rafizadeh, D Elahi, JM Egan |
Journal of Clinical Investigation | 1997 |
|
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice
RN Kulkarni, ZL Wang, RM Wang, JD Hurley, DM Smith, MA Ghatei, DJ Withers, JV Gardiner, CJ Bailey, SR Bloom |
Journal of Clinical Investigation | 1997 |
|
ENTEROGLUCAGON
JJ Holst |
Annual Review of Physiology | 1997 |
|
Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness
C Montrose-Rafizadeh, Y Wang, AM Janczewski, TE Henderson, JM Egan |
Molecular and Cellular Endocrinology | 1997 |
|
GIP6–30amide contains the high affinity binding region of GIP and is a potent inhibitor of GIP1–42action in vitro
RW Gelling, DH Coy, RA Pederson, MB Wheeler, S Hinke, T Kwan, CH McIntosh |
Regulatory Peptides | 1997 |
|
Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle
A I Alcántara, M Morales, E Delgado, M I López-Delgado, F Clemente, M A Luque, W J Malaisse, I Valverde, M L Villanueva-Peñacarrillo |
Archives of Biochemistry and Biophysics | 1997 |
|
Tissue-specific Expression of Unique mRNAs That Encode Proglucagon-derived Peptides or Exendin 4 in the Lizard
YE Chen, DJ Drucker |
The Journal of biological chemistry | 1997 |
|
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
N Imeryüz, BÇ Yeğen, A Bozkurt, T Coşkun, ML Villanueva-Peñacarrillo, NB Ulusoy |
AJP Gastrointestinal and Liver Physiology | 1997 |
|
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
MA Nauck, U Niedereichholz, R Ettler, JJ Holst, C Ørskov, R Ritzel, WH Schmiegel |
American journal of physiology. Endocrinology and metabolism | 1997 |
|
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons
DA D'Alessio, R Vogel, R Prigeon, E Laschansky, D Koerker, J Eng, JW Ensinck |
Journal of Clinical Investigation | 1996 |
|
Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat
CC Tseng, TJ Kieffer, LA Jarboe, TB Usdin, MM Wolfe |
Journal of Clinical Investigation | 1996 |
|
Pancreatic β-Cell Receptors and G Proteins Coupled to Adenylyl Cyclase
JC Marie, G Rosselin, G Skoglund |
Annals of the New York Academy of Sciences | 1996 |
|
Fermentable carbohydrate modulates postprandial enteroglucagon and gastrin release in rats
JM Gee, W Lee-Finglas, IT Johnson |
British Journal of Nutrition | 1996 |
|
Comparison of the glucose dependency of glucagon-like peptide-1(7–37) and glyburide in vitro and in vivo
DM Hargrove, NA Nardone, LM Persson, KM Andrews, KL Shepherd, RW Stevenson, JC Parker |
Metabolism | 1996 |
|
Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats
JM Barragán, RE Rodríguez, J Eng, E Blázquez |
Regulatory Peptides | 1996 |
|
The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic polypeptide, in the portal vein
M Nishizawa, H Nakabayashi, K Uchida, A Nakagaw, A Niijima |
Journal of the Autonomic Nervous System | 1996 |
|
Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day
C Ørskov, A Wettergren, JJ Holst |
Scandinavian Journal of Gastroenterology | 1996 |
|
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1
H Nakabayashi, M Nishizawa, A Nakagawa, R Takeda, A Niijima |
American journal of physiology. Endocrinology and metabolism | 1996 |
|
A role for glucagon-like peptide-1 in the central regulation of feeding
MD Turton, D O'Shea, I Gunn, SA Beak, CM Edwards, K Meeran, SJ Choi, GM Taylor, MM Heath, PD Lambert, JP Wilding, DM Smith, MA Ghatei, J Herbert, SR Bloom |
Nature | 1996 |
|
Glucagon III
PJ Lefèbvre |
1996 | |
|
Glucagon-like peptide-1 (GLP-1): a piece of the incretin puzzle
GC Weir |
Journal of Clinical Investigation | 1995 |
|
Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets
SG Laychock |
Molecular and Cellular Endocrinology | 1995 |
|
Gastrointestinal Endocrinology
CC Wang, YH Tu, WY Zhu |
Gastrointestinal Endocrinology | 1990 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)